Effects of inhibitory rTMS on bladder function in Parkinson's disease patients

Mov Disord. 2009 Feb 15;24(3):445-8. doi: 10.1002/mds.22434.

Abstract

Patients affected by Parkinson's disease (PD) may present with lower urinary tract (LUT) dysfunction characterized by involuntary detrusor overactivity. We evaluated possible impact of a 2-week course of low frequency 1 Hz repetitive transcranial magnetic stimulation (rTMS) on LUT behavior in eight advanced PD patients complaining of urinary disturbances. We tested the effects of rTMS measuring urodynamic examination and the International Prostate Symptoms Score (IPSS) questionnaire, used for evaluation of subjective LUTS. rTMS was able to improve temporarily LUT behavior in PD patients, increasing bladder capacity and the first sensation of filling phase. Moreover, a reduction of IPSS score was noticed, due to an improvement on filling phase symptoms. The beneficial effects assessed with the IPSS lasted for up to 2 weeks after the end of the stimulation. rTMS seems to be an effective, noninvasive alternative treatment for PD patients with urinary disturbances.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antiparkinson Agents / therapeutic use
  • Female
  • Humans
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy
  • Parkinson Disease / epidemiology*
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / epidemiology
  • Severity of Illness Index
  • Surveys and Questionnaires
  • Time Factors
  • Transcranial Magnetic Stimulation / methods*
  • Urinary Bladder, Overactive* / epidemiology
  • Urinary Bladder, Overactive* / physiopathology
  • Urinary Bladder, Overactive* / therapy
  • Urodynamics

Substances

  • Antiparkinson Agents
  • Levodopa